Current strategies in hormonal manipulation of advanced prostate cancer
- 1 October 1991
- journal article
- Published by Wolters Kluwer Health in Current Opinion in Urology
- Vol. 1 (1) , 16-20
- https://doi.org/10.1097/00042307-199110000-00006
Abstract
Initial treatment choice depends partly on the patient's preference. Tumor models elucidated genetic influence, threshold tissue levels of activity and mechanism of actions. Luteotrope hormone-releasing hormone agonists and antiandrogens are integrated in clinical practice. Imidazole derivations, 5α-reductase blockers and growth-factor antagonists offer clinical potential.This publication has 0 references indexed in Scilit: